6669 Stock Overview
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Acotec Scientific Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$6.48 |
| 52 Week High | HK$17.00 |
| 52 Week Low | HK$5.80 |
| Beta | 0.085 |
| 1 Month Change | -19.00% |
| 3 Month Change | -21.93% |
| 1 Year Change | -55.49% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -63.18% |
Recent News & Updates
Recent updates
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 46% Undervalued
Mar 21
We Think Acotec Scientific Holdings (HKG:6669) Can Easily Afford To Drive Business Growth
Nov 17Acotec Scientific Holdings Limited's (HKG:6669) Intrinsic Value Is Potentially 42% Above Its Share Price
Oct 20Acotec Scientific Holdings (HKG:6669) Has More To Do To Multiply In Value Going Forward
Sep 24An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued
Jul 01Shareholder Returns
| 6669 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -6.2% | 4.1% | 3.6% |
| 1Y | -55.5% | -49.9% | -10.1% |
Return vs Industry: 6669 underperformed the Hong Kong Medical Equipment industry which returned -49.9% over the past year.
Return vs Market: 6669 underperformed the Hong Kong Market which returned -10.1% over the past year.
Price Volatility
| 6669 volatility | |
|---|---|
| 6669 Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.6% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 6669's share price has been volatile over the past 3 months.
Volatility Over Time: 6669's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 638 | Jing Li | www.acotec.cn |
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products worldwide. The company was founded in 2011 and is based in Beijing, China. As of February 8, 2023, Acotec Scientific Holdings Limited operates as a subsidiary of Boston Scientific Group Public Limited Company.
Acotec Scientific Holdings Limited Fundamentals Summary
| 6669 fundamental statistics | |
|---|---|
| Market cap | HK$2.03b |
| Earnings (TTM) | HK$15.65m |
| Revenue (TTM) | HK$511.98m |
129.7x
P/E Ratio4.0x
P/S RatioIs 6669 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6669 income statement (TTM) | |
|---|---|
| Revenue | CN¥473.85m |
| Cost of Revenue | CN¥96.43m |
| Gross Profit | CN¥377.42m |
| Other Expenses | CN¥362.93m |
| Earnings | CN¥14.49m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.046 |
| Gross Margin | 79.65% |
| Net Profit Margin | 3.06% |
| Debt/Equity Ratio | 0.8% |
How did 6669 perform over the long term?
See historical performance and comparison